Clinical trial using immunotherapy drug combinations to treat lung cancer appears safe

Pembrolizumab, an immunotherapy drug that unmasks cancer cells and allows the body's immune system to destroy tumors, appears to be safe in treating lung cancers, according to a study.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1O7B3NL